Remarkably, a recent study reported a potential protective association of CHIP with DNMT3A mutation with diabetic polyneuropathy in patients with type 2 diabetes, whereas TET2 mutation showed a positive association.36 This evidence concerns the gene DNMT3A and diabetic polyneuropathy.